Agios Pharmaceuticals Inc’s recent filing unveils that its Chief Legal Officer Burns James William unloaded Company’s shares for reported $0.14 million on Mar 03 ’25. In the deal valued at $35.54 per share,4,005 shares were sold. As a result of this transaction, Burns James William now holds 18,650 shares worth roughly $0.58 million.
Then, Jones Cecilia sold 2,275 shares, generating $80,854 in total proceeds. Upon selling the shares at $35.54, the Chief Financial Officer now owns 21,843 shares.
Before that, Milanova Tsveta sold 1,681 shares. Agios Pharmaceuticals Inc shares valued at $59,743 were divested by the Chief Commercial Officer at a price of $35.54 per share. As a result of the transaction, Milanova Tsveta now holds 22,892 shares, worth roughly $0.71 million.
H.C. Wainwright initiated its Agios Pharmaceuticals Inc [AGIO] rating to a Buy in a research note published on February 24, 2025; the price target was $58. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid October with a ‘”a Sector outperform”‘ rating. Leerink Partners revised its rating on September 27, 2024. It rated AGIO as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of AGIO
On Friday, Agios Pharmaceuticals Inc [NASDAQ:AGIO] saw its stock fall -0.45% to $30.93. Over the last five days, the stock has lost -4.48%. Agios Pharmaceuticals Inc shares have fallen nearly -5.87% since the year began. Nevertheless, the stocks have risen 2.11% over the past one year. While a 52-week high of $62.58 was reached on 02/24/25, a 52-week low of $27.14 was recorded on 03/14/25. SMA at 50 days reached $33.61, while 200 days put it at $42.87.
Levels Of Support And Resistance For AGIO Stock
The 24-hour chart illustrates a support level at 30.61, which if violated will result in even more drops to 30.29. On the upside, there is a resistance level at 31.55. A further resistance level may holdings at 32.17. The Relative Strength Index (RSI) on the 14-day chart is 34.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.85, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.61%. Stochastics %K at 4.93% indicates the stock is a buying.
How much short interest is there in Agios Pharmaceuticals Inc?
A steep rise in short interest was recorded in Agios Pharmaceuticals Inc stocks on 2025-02-28, dropping by -1.09 million shares to a total of 3.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 5.03 million shares. There was a decline of -27.62%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 08, 2024 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating .
